Invesco’s Greenwich LifeSciences GLSI Stock Holding History

Invesco’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-148,087	Closed	-$5.79M	–	4055
2021 Q3	$5.79M	Sell	148,087 -131,975	-47%	-$5.51M	﹤0.01%	2307
2021 Q2	$12.6M	Buy	+280,062	New	+$10.6M	﹤0.01%	1915

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Invesco's GLSI Position: Q4 2021 in Review

Invesco sold out of Greenwich LifeSciences (GLSI) in Q4 2021, closing a stake of 148,087 shares — an estimated $5.79M sold.

Invesco first reported a position in GLSI in Q2 2021 and held it in 2 quarters. The position peaked at $12.6M in Q2 2021. 35 funds tracked by Wall St. Rank hold GLSI as of Q4 2021.

Invesco reported no remaining Greenwich LifeSciences position as of Q4 2021 after selling out during the quarter.
Invesco sold 148,087 Greenwich LifeSciences shares in Q4 2021, an estimated $5.79M.
Invesco first reported a position in Greenwich LifeSciences in Q2 2021 and held it in 2 quarters.
Invesco's Greenwich LifeSciences position peaked at $12.6M in Q2 2021.
35 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q4 2021.

Based on Invesco's 13F filing for Q4 2021, filed 14 Feb 2022.